Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Sell
10,293
-1,411
-12% -$154K 0.01% 873
2026
Q1
$972K Sell
11,704
-43
-0.4% -$3.68K 0.01% 888
2025
Q4
$1M Sell
11,747
-181
-2% -$15.1K 0.01% 811
2025
Q3
$997K Sell
11,928
-3,272
-22% -$299K 0.01% 829
2025
Q2
$1.54M Sell
15,200
-756
-5% -$77.1K 0.02% 595
2025
Q1
$1.69M Buy
15,956
+412
+3% +$42.7K 0.02% 534
2024
Q4
$1.7M Buy
15,544
+4,038
+35% +$470K 0.03% 458
2024
Q3
$1.67M Buy
11,506
+926
+9% +$126K 0.04% 455
2024
Q2
$1.54M Buy
+10,580
New +$1.48M 0.04% 456

Other funds holding CROX

Vident Advisory's CROX Position: Q2 2026 in Review

Vident Advisory reduced its Crocs (CROX) stake by 12% in Q2 2026, selling an estimated $154K and leaving 10,293 shares worth $1.24M. The position accounts for 0.01% of the portfolio, ranked #873.

Vident Advisory first reported a position in CROX in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.7M in Q4 2024. 502 funds tracked by Wall St. Rank hold CROX as of Q2 2026.

  • Vident Advisory held 10,293 shares of Crocs worth $1.24M as of Q2 2026.
  • Vident Advisory sold 1,411 Crocs shares in Q2 2026, an estimated $154K.
  • Crocs made up 0.01% of Vident Advisory's portfolio in Q2 2026, its #873 holding.
  • Vident Advisory first reported a position in Crocs in Q2 2024 and has held it in 9 quarters since.
  • Vident Advisory's Crocs position peaked at $1.7M in Q4 2024.
  • 502 funds tracked by Wall St. Rank held Crocs as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.